BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21450947)

  • 41. Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells.
    De Falco G; Leucci E; Onnis A; Bellan C; Tigli C; Wirths S; Cerino G; Cocco M; Crupi D; De Luca A; Lanzavecchia A; Tosi P; Leoncini L; Giordano A
    J Cell Physiol; 2008 Apr; 215(1):276-82. PubMed ID: 18205180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication.
    Ziehr B; Lenarcic E; Cecil C; Moorman NJ
    Virology; 2016 Feb; 489():194-201. PubMed ID: 26773380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication.
    Hamilton ST; Hutterer C; Egilmezer E; Steingruber M; Milbradt J; Marschall M; Rawlinson WD
    Placenta; 2018 Dec; 72-73():10-19. PubMed ID: 30501876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
    Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer.
    Li J; Liu T; Song Y; Wang M; Liu L; Zhu H; Li Q; Lin J; Jiang H; Chen K; Zhao K; Wang M; Zhou H; Lin H; Luo C
    J Med Chem; 2022 Aug; 65(16):11034-11057. PubMed ID: 35925880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting cyclin-dependent kinase 9 in cancer therapy.
    Shen YL; Wang YM; Zhang YX; Ma SJ; Yang LH; Zhao CG; Huang XY
    Acta Pharmacol Sin; 2022 Jul; 43(7):1633-1645. PubMed ID: 34811514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.
    Steingruber M; Socher E; Hutterer C; Webel R; Bergbrede T; Lenac T; Sticht H; Marschall M
    Viruses; 2015 Aug; 7(8):4582-601. PubMed ID: 26270673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study.
    Jin HX; Go ML; Yin P; Qiu XT; Zhu P; Yan XJ
    PLoS One; 2015; 10(4):e0124673. PubMed ID: 25909811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cytomegalovirus RNA2.7 inhibits RNA polymerase II (Pol II) Serine-2 phosphorylation by reducing the interaction between Pol II and phosphorylated cyclin-dependent kinase 9 (pCDK9).
    Huang Y; Guo X; Zhang J; Li J; Xu M; Wang Q; Liu Z; Ma Y; Qi Y; Ruan Q
    Virol Sin; 2022 Jun; 37(3):358-369. PubMed ID: 35537980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Interactive Complex between Cytomegalovirus Kinase vCDK/pUL97 and Host Factors CDK7-Cyclin H Determines Individual Patterns of Transcription in Infected Cells.
    Schütz M; Cordsmeier A; Wangen C; Horn AHC; Wyler E; Ensser A; Sticht H; Marschall M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1.
    Aoyagi M; Gaspar M; Shenk TE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2640-5. PubMed ID: 20133758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the Cdk9/Cyclin T1 complex in T cell differentiation.
    Leucci E; De Falco G; Onnis A; Cerino G; Cocco M; Luzzi A; Crupi D; Tigli C; Bellan C; Tosi P; Leoncini L; Giordano A
    J Cell Physiol; 2007 Aug; 212(2):411-5. PubMed ID: 17352406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.
    Eifler M; Uecker R; Weisbach H; Bogdanow B; Richter E; König L; Vetter B; Lenac-Rovis T; Jonjic S; Neitzel H; Hagemeier C; Wiebusch L
    PLoS Pathog; 2014 Oct; 10(10):e1004514. PubMed ID: 25393019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex.
    Lin R; Yang J; Liu T; Wang M; Ke C; Luo C; Lin J; Li J; Lin H
    Chem Biodivers; 2023 Aug; 20(8):e202300769. PubMed ID: 37349855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of the human cytomegalovirus (HCMV) tegument protein UL69 to UAP56/URH49 is not required for efficient replication of HCMV.
    Kronemann D; Hagemeier SR; Cygnar D; Phillips S; Bresnahan WA
    J Virol; 2010 Sep; 84(18):9649-54. PubMed ID: 20610707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency.
    Schütz M; Wangen C; Sommerer M; Kögler M; Eickhoff J; Degenhart C; Klebl B; Naing Z; Egilmezer E; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
    Virus Res; 2023 Oct; 335():199200. PubMed ID: 37591314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription.
    Um HJ; Kim M; Lee SH; Kim YH
    AIDS; 2012 Aug; 26(13):1599-605. PubMed ID: 22569018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.
    Darbinian N; Sawaya BE; Khalili K; Jaffe N; Wortman B; Giordano A; Amini S
    J Neuroimmunol; 2001 Dec; 121(1-2):3-11. PubMed ID: 11730934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.